levonorgestrel has been researched along with HIV in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 2 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ayele, H; Baeten, JM; Bosinger, SE; Brown, BP; Bunjun, R; Burgener, A; Dabee, S; Gamieldien, H; Harryparsad, R; Heffron, R; Heller, KB; Jaspan, H; Jaumdally, SZ; Nair, G; Noël-Romas, L; Onono, M; Palanee-Phillips, T; Passmore, JS; Ramla, TF; Scoville, CW | 1 |
Back, S; Horgan, C; Marcus, JL; Murray Horwitz, ME; Rajbhandari, R; Snowden, JM; Tilney, RC; Toh, S; Westreich, DJ | 1 |
Sathyamala, C | 1 |
Chinula, L; Ellington, S; Haddad, LB; Hosseinipour, MC; Hurst, S; Kourtis, AP; Mataya, R; Msika, A; Nelson, JAE; Tang, JH; Tegha, G; Wiener, J | 1 |
Baiamonte, L; Drobnis, EZ; Hope, TJ; Huang, L; Li, L; Mills, M; Quayle, AJ; Schust, DJ; Stark, M; Tu, J; Wang, W; Zhou, J | 1 |
Byamugisha, JK; Gemzell-Danielsson, K; Kakaire, O; Tumwesigye, NM | 1 |
Blanchard, J; Calenda, G; Cooney, ML; Fernández-Romero, JA; Gettie, A; Kizima, L; Mizenina, O; Robbiani, M; Teleshova, N; Ugaonkar, S; Villegas, G; Zhang, S; Zydowsky, TM | 1 |
Heikinheimo, O; Lehtovirta, P; Paavonen, J; Suni, J | 1 |
3 trial(s) available for levonorgestrel and HIV
Article | Year |
---|---|
Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Topics: Contraceptive Agents, Female; Copper; Disease Susceptibility; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Proteomics; South Africa; Vagina | 2022 |
Effect of the depot medroxyprogesterone acetate injectable and levonorgestrel implant on HIV genital shedding: a randomized trial.
Topics: Adult; Anti-Retroviral Agents; Contraceptive Agents, Female; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Vaginal Smears; Virus Shedding | 2018 |
Acceptability of intrauterine contraception among women living with human immunodeficiency virus: a randomised clinical trial.
Topics: Adult; Contraception; Contraceptive Agents, Female; Female; HIV; Humans; Interviews as Topic; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Middle Aged; Patient Satisfaction; Uganda; Women's Health | 2016 |
5 other study(ies) available for levonorgestrel and HIV
Article | Year |
---|---|
Use of Intrauterine Devices and Risk of Human Immunodeficiency Virus Acquisition Among Insured Women in the United States.
Topics: Female; HIV; HIV Infections; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; United States | 2020 |
Depot contraception and HIV: an exercise in obfuscation.
Topics: Contraception; Contraceptive Agents, Female; Female; HIV; Humans; Incidence; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate | 2019 |
Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
Topics: Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Young Adult | 2019 |
A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo.
Topics: Animals; Anti-Infective Agents; Carrageenan; Contraceptive Agents, Female; Contraceptive Devices, Female; Drug Combinations; Female; HIV; Levonorgestrel; Macaca mulatta; Mucous Membrane; Pyridines; Reassortant Viruses; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Treatment Outcome; Urea; Vagina; Zinc Acetate | 2016 |
The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women--effects on bleeding patterns, ovarian function and genital shedding of HIV.
Topics: Contraceptive Agents, Female; Estradiol; Female; HIV; HIV Infections; Humans; Levonorgestrel; Menstruation; Ovary; Prospective Studies; Uterus; Viral Load; Virus Shedding | 2006 |